Search Results 1051-1060 of 17160 for treatment resistant depression

1. Behcet disease - Diagnosis and treatment - Mayo Clinic

   ... treatment of mouth sores caused by Behcet disease. Side effects may include weight loss and depression. If you have more-serious Behcet disease, you may ...

2. Find clinical trials - Oncology (Medical)

   CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...

3. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia. Print ...

4. Clinical trials - Oncology (Medical)

   ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia. Patients ... treatment (including ...

5. A Study to Evaluate the Use of AR-42 (Histone Deacetylase Inhibitor) in the Treatment of Vestibular Schwannoma and Meningioma - Mayo Clinic

   Meningiomas are outside the BBB, but also seem to be unusually resistant to all current medical treatments. Participation eligibility. Participant ...

6. Assessing the long-term risk of mood and anxiety disorders after pediatric TBI - Mayo Clinic

   ... treatment guidelines," says Dr. Esterov. Study ... "When patients do sustain a TBI during childhood, this does not necessarily increase their risk for depression ...

7. Complex decongestive therapy may benefit patients seen in the chronic disease and palliative care settings - Mayo Clinic

   Managing refractory edema in patients receiving palliative care - The goal of complex decongestive therapy is to normalize tissue volume and texture.

8. Spinal Cord Lymphoma Clinical Trials - Mayo Clinic Research

   This phase I clinical trial aims to elucidate the maximal tolerated dose and side effects of pomalidomide in patients with relapsed or refractory primary ...

9. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

   The purpose of this study is to characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell ...

10. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...